We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Curium Gallium (Ga-67) citrate 37 MBq/ml solution for injection (UK)
Section 19A approved medicine
(Approval lapsed) Curium Gallium (Ga-67) citrate 37 MBq/ml solution for injection (UK)
Section 19A approval holder
Global Medical Solutions Australia ABN: 66 072 147 561
Phone
(02) 9503 8100
Approved until
Status
Expired
Medicines in short supply/unavailable
LANTHEUS GALLIUM(67Ga) citrate 74MBq/mL injection USP multidose vial - ARTG 19144
Indication(s)
Gallium Citrate Ga 67 Injection, U.S.P. may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.
Additional information
Please note the safety and efficacy of LANTHEUS GALLIUM (67Ga) citrate 74MBq/mL injection USP multidose vial ARTG 19144 for use in infants and children has not been established. As such, the use of Curium Gallium (Ga-67) citrate 37MBq/ml solution for injection (UK) for radiopharmaceutical preparation is not recommended for use in infants and children.
Images
